These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 15577032

  • 21. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease.
    Goodman WG.
    Semin Dial; 2004; 17(3):209-16. PubMed ID: 15144547
    [Abstract] [Full Text] [Related]

  • 22. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 23. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H, Akizawa T.
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [Abstract] [Full Text] [Related]

  • 24. New therapies for uremic secondary hyperparathyroidism.
    Torres PU, Prié D, Beck L, Friedlander G.
    J Ren Nutr; 2006 Apr; 16(2):87-99. PubMed ID: 16567265
    [Abstract] [Full Text] [Related]

  • 25. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
    Cunningham J, Locatelli F, Rodriguez M.
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):913-21. PubMed ID: 21454719
    [Abstract] [Full Text] [Related]

  • 26. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
    Mizobuchi M, Aoshima Y, Akizawa T.
    Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177
    [Abstract] [Full Text] [Related]

  • 27. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS, Slatopolsky E, Reiss E, Avioli LV.
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract] [Full Text] [Related]

  • 28. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet.
    Uchiyama T, Tatsumi N, Kamejima S, Waku T, Ohkido I, Yokoyama K, Yokoo T, Okabe M.
    Hum Cell; 2016 Oct; 29(4):155-61. PubMed ID: 27589858
    [Abstract] [Full Text] [Related]

  • 29. Nutritional secondary hyperparathyroidism in rabbits.
    Bas S, Bas A, López I, Estepa JC, Rodríguez M, Aguilera-Tejero E.
    Domest Anim Endocrinol; 2005 May; 28(4):380-90. PubMed ID: 15826773
    [Abstract] [Full Text] [Related]

  • 30. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME.
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [Abstract] [Full Text] [Related]

  • 31. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J, Liu S, Quarles LD.
    Semin Dial; 2007 Mar; 20(4):302-8. PubMed ID: 17635819
    [Abstract] [Full Text] [Related]

  • 32. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
    Fernández Martín JL, González Suárez I, Cannata Andía JB.
    Nefrologia; 2003 Mar; 23 Suppl 2():7-11. PubMed ID: 12778846
    [Abstract] [Full Text] [Related]

  • 33. Vitamin D treatment in chronic kidney disease.
    Andress DL.
    Semin Dial; 2005 Mar; 18(4):315-21. PubMed ID: 16076355
    [Abstract] [Full Text] [Related]

  • 34. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
    Lezaic V, Pejanovic S, Kostic S, Pljesa S, Dimkovic N, Komadina L, Jovanovic D, Marinkovic J, Djukanovic L.
    Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
    [Abstract] [Full Text] [Related]

  • 35. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A.
    J Nephrol; 2005 Apr; 18(1):5-8. PubMed ID: 15772917
    [Abstract] [Full Text] [Related]

  • 36. Inherited disorders of calcium homeostasis.
    Ramasamy I.
    Clin Chim Acta; 2008 Aug; 394(1-2):22-41. PubMed ID: 18474231
    [Abstract] [Full Text] [Related]

  • 37. [Anomalies of phosphate and calcium metabolism in chronic renal insufficiency].
    Drüeke TB.
    Rev Prat; 1998 Jun 01; 48(11):1207-12. PubMed ID: 9781173
    [Abstract] [Full Text] [Related]

  • 38. [Secondary hyperparathyroidism].
    Nakanishi S, Fukagawa M.
    Nihon Rinsho; 2005 Oct 01; 63 Suppl 10():341-6. PubMed ID: 16279659
    [No Abstract] [Full Text] [Related]

  • 39. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Oct 01; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 40. The role of vitamin D in vascular calcification in chronic kidney disease.
    Wolisi GO, Moe SM.
    Semin Dial; 2005 Oct 01; 18(4):307-14. PubMed ID: 16076354
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.